Chronic Pain Clinical Trials

Find Chronic Pain Clinical Trials Near You

Lateral Plantar Artery Embolization to Treat Pain Chronic Heel Pain Due To Plantar Fasciitis A Pilot Study to Assess Feasibility

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Phase 1
SUMMARY

The goal of this clinical trial is to learn if lateral plantar artery embolization using Lipiodol can safely and effectively treat chronic heel pain due to plantar fasciitis in adults aged 25 to 80. The main questions it aims to answer are: Does this procedure successfully reduce chronic heel pain as measured by the Visual Analog Scale (VAS) over 12 months? How safe is the procedure, specifically regarding the frequency of serious medical problems or adverse events related to the device? Participants will: Undergo a minimally invasive procedure where a doctor uses a small tube (catheter) to inject a temporary blocking agent (LipioJoint) into specific blood vessels in the foot. Receive a phone call one day after the procedure to check for early side effects. Participate in four follow-up telehealth visits over the course of one year (at 1, 3, 6, and 12 months). Complete pain intensity surveys (VAS) and report any changes in their use of other therapies or medications during these visits.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 25
Maximum Age: 80
Healthy Volunteers: f
View:

• Age ≥ 25 years

• Subject provides written informed consent

• Patient with Plantar Fasciitis refractory to 3 months of conservative management

• Self reported pain of at least 4/10 on visual analog scale (VAS)

• Non-surgical candidate/looking to avoid surgery

Locations
United States
Illinois
Joint and Vascular Institute
RECRUITING
Libertyville
Contact Information
Primary
Layth Alkhani
lalkhani@jointvascular.com
847-584-3959
Time Frame
Start Date: 2025-12-20
Estimated Completion Date: 2027-03
Participants
Target number of participants: 10
Treatments
Experimental: Lateral Plantar Artery Embolization
Related Therapeutic Areas
Sponsors
Leads: Joint & Vascular Institute

This content was sourced from clinicaltrials.gov